Astria Therapeutics, Inc.
ATXS$718M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaBOSTON78 employees
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Mar 15, 2027
45wMarket Overview
Stock performance and key metrics
ATXS News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
navenibart | Phase 3 | Hereditary Angioedema (HAE) | - | - |
STAR-0215 | Phase 2 | Hereditary Angioedema | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply